Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
149 Leser
Artikel bewerten:
(0)

Alcami Sponsors Employee Engagement Day at Students 2 Science

WILMINGTON, North Carolina, July 13, 2016 /PRNewswire/ -- Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announced its participation and support of resources, money and volunteers to Students 2 Science (S2S), Inc. S2S is an innovative Science, Technology, Engineering and Math (STEM) education organization that introduces elementary, middle, and high school students from throughout the state of New Jersey and Pennsylvania to real-world science and scientists at its professional laboratory in East Hanover and through its virtual lab program.

Logo - http://photos.prnewswire.com/prnh/20160315/344471LOGO

Alcami joins other pharma and biotech companies in a common goal to make STEM activities and education in math and science fun and exciting. "There is no other program like Students2Science. This is a unique program that truly makes learning science fun. We are engaging the next generation of chemical engineers and bench scientists, as well as our future executives in the pharmaceutical industry," stated Dr. Stephan Kutzer, CEO, President and Chairman of Alcami Corporation. A STEM education not only serves students well in pursing careers in science, but also provides a 'leg up' to students wanting to work in various roles within the pharmaceutical industry, or who aren't sure what they want to become.

Over 20 volunteers from different sites across the United States participated in the first Pharma Day of the year, including Alcami's Chief Operating Officer, Ted Dolan, Chief Commercial Officer, Syed Husain, and Vice President of Quality & Regulatory Affairs, Brian Dillion. Volunteers and full time staff from S2S joined eleventh and twelfth graders from High Tech High School, in Middletown, NJ. Each volunteer shared their background and spoke about their involvement with science growing up. All of the volunteers had scientific education and play different roles within the pharmaceutical industry: proof that a degree in science can lead to a variety of different career opportunities.

ABOUT STUDENTS 2 SCIENCE
Students 2 Science, Inc. is a 501(c)(3) is model program bridging the needs of the public and private sectors located in New Jersey. Our mission is to inspire, motivate, and educate elementary, middle and high school students to pursue careers in science, technology, engineering and math (STEM subjects). We do so by providing an authentic, state of the art laboratory experience complete with modern instrumentation and professional scientists as well as virtual through our V-Lab program. Teams of students, working collaboratively with scientific professionals serving as role models, solve real life problems while being introduced to a wide variety of STEM career opportunities. For more information, go to www.students2science.org.

Follow us on social media:
Facebook: www.facebook.com/Students2Science

ABOUT ALCAMI
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form Alcami, a world class supplier of comprehensive pharmaceutical development and manufacturing services. With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. For more information, visit us at www.alcaminow.com


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.